Friday 4 October 2019

Bone Loss and Antiretroviral Therapy in HIV and HCV

Among the numerous comorbidities that affect people living with HIV (PLWH), an increased prevalence of osteopenia and osteoporosis has been observed across a range of studies. The etiology of reduced bone mineral density (BMD) in this population has been linked to various factors, including those associated with HIV infection and treatment, as well as unrelated factors.


As a result, PLWH has a greater prevalence of fractures compared with the general population, with one study showing rates of 2.87 vs 1.77 per 100 people per year, especially involving the spine, hip, and wrist.

Spread knowledge relevant to your area of interest with us in Paris, France: https://chronicdiseases.cmesociety.com/

No comments:

Post a Comment

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome   (CFS) is a chronic disease and the individual shows extreme tiredness pain and sleep disorders that persist ...